You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Enhancer of zeste homolog (EZH) inhibitor

Showing 1 - 25 of 7,512
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma Trial in Worldwide (Valemetostat Tosylate)

Recruiting
  • Relapsed/Refractory Peripheral T-Cell Lymphoma
  • Adult T Cell Leukemia/Lymphoma
  • Valemetostat Tosylate
  • Duarte, California
  • +59 more
Jun 3, 2022

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Non Small Cell Lung Cancer Trial in West Los Angeles (Tazemetostat)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • West Los Angeles, California
    VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Jul 21, 2022

Relapsed or Refractory Follicular Lymphoma With Enhancer of

Recruiting
  • Lymphoma, Follicular
  • Anjo-shi, Aichi, Japan
  • +174 more
Dec 12, 2022

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

B-cell Lymphomas (Phase 1), Advanced Solid Tumors (Phase 1), Diffuse Large B-cell Lymphoma (Phase 2) Trial in Worldwide

Completed
  • B-cell Lymphomas (Phase 1)
  • +5 more
  • Birmingham, Alabama
  • +51 more
Dec 8, 2021

Solid Tumor, Lymphoma Trial in Beijing (SHR2554+SHR1701, SHR1701)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Beijing, China
    Department of Biotherapeutic, Chinese PLA General Hospital
Sep 22, 2020

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

Terminated
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Boston, Massachusetts
  • +5 more
Jun 11, 2021

Peripheral Nerve Sheath Tumor Trial in Gainesville (Tazemetostat)

Recruiting
  • Peripheral Nerve Sheath Tumor
  • Gainesville, Florida
    University of Florida
Jan 4, 2023

Hepatic Impairment Trial in Miami, Orlando, San Antonio (DS-3201b)

Completed
  • Hepatic Impairment
  • Miami, Florida
  • +2 more
Feb 24, 2021

CNS Lymphoma, Gastric Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Houston (Akt/ERK Inhibitor ONC201,

Terminated
Has Results
  • Central Nervous System Lymphoma
  • +6 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 30, 2022

Listening Effort Trial (Speech Enhancer)

Not yet recruiting
  • Listening Effort
  • Speech Enhancer
  • (no location specified)
Sep 14, 2023

Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Tucson, Arizona
  • +62 more
Jan 18, 2023

Urinary Stones Trial in United States (Ureteroscopy Laser Lithotripsy (URS-LL) with Acoustic Enhancer, Standard Ureteroscopic

Recruiting
  • Urinary Stones
  • Ureteroscopy Laser Lithotripsy (URS-LL) with Acoustic Enhancer
  • Standard Ureteroscopic Laser Lithotripsy
  • Birmingham, Alabama
  • +26 more
Jan 4, 2023

Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

Not yet recruiting
  • Schizophrenia
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Sep 4, 2023

Follicular Lymphoma, Endometrial Cancer Trial in New York (Copanlisib, Ketogenic Diet)

Recruiting
  • Follicular Lymphoma
  • Endometrial Cancer
  • New York, New York
  • +2 more
Nov 24, 2021

Metastatic Adenocarcinoma of the Pancreas Trial in Soeul (Minnelide)

Recruiting
  • Metastatic Adenocarcinoma of the Pancreas
  • Minnelide
  • Soeul, Korea, Republic of
    Samsung Medical Center
Dec 8, 2022

Advanced Solid Tumors Trial in Worldwide (MK-1084, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +39 more
Jan 25, 2023

KRAS P.G12C Trial in Worldwide (D3S-001)

Recruiting
  • KRAS P.G12C
  • Detroit, Michigan
  • +12 more
Jan 16, 2023

Bipolar I Disorder Trial (NMDAE, Placebo Cap)

Not yet recruiting
  • Bipolar I Disorder
  • (no location specified)
Aug 3, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

Terminated
Has Results
  • Cancer
  • Solid Tumors
  • Las Vegas, Nevada
  • +5 more
Jun 14, 2022

Vectibix With Chemotherapy for Metastatic Colorectal Cancer

Completed
Has Results
  • Wild-type RAS Metastatic Colorectal Cancer
  • Panitumumab + Chemotherapy
  • (no location specified)
Nov 4, 2022

Autism Spectrum Disorder Trial in New Haven (Oxytocin, Pivotal Response Treatment, Placebo)

Terminated
Has Results
  • Autism Spectrum Disorder
  • New Haven, Connecticut
    Yale School of Medicine
Aug 8, 2022

Advanced and/or Metastatic Solid Tumours Trial in Netherlands, United Kingdom (CB307)

Recruiting
  • Advanced and/or Metastatic Solid Tumours
  • Amsterdam, Noord-Holland, Netherlands
  • +9 more
Apr 21, 2022